Janiczek Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$150K Sell
5,370
-1,960
-27% -$54K 0.03% 225
2024
Q1
$203K Sell
7,330
-2,487
-25% -$69K 0.04% 176
2023
Q4
$283K Sell
9,817
-3,580
-27% -$108K 0.07% 116
2023
Q3
$444K Buy
13,397
+1,425
+12% +$50.4K 0.12% 72
2023
Q2
$439K Sell
11,972
-1,553
-11% -$60.4K 0.12% 64
2023
Q1
$557K Sell
13,525
-4,012
-23% -$173K 0.16% 47
2022
Q4
$837K Buy
17,537
+1,067
+6% +$51.2K 0.24% 37
2022
Q3
$688K Sell
16,470
-359
-2% -$17.4K 0.22% 39
2022
Q2
$855K Buy
16,829
+2,635
+19% +$134K 0.25% 38
2022
Q1
$735K Sell
14,194
-160
-1% -$8.3K 0.2% 42
2021
Q4
$848K Buy
14,354
+872
+6% +$43.2K 0.25% 35
2021
Q3
$580K Buy
13,482
+455
+3% +$20.2K 0.21% 39
2021
Q2
$510K Buy
13,027
+522
+4% +$20.3K 0.19% 42
2021
Q1
$453K Sell
12,505
-401
-3% -$14.2K 0.18% 40
2020
Q4
$475K Buy
12,906
+491
+4% +$18K 0.23% 33
2020
Q3
$432K Buy
12,415
+10,989
+771% +$385K 0.23% 31
2020
Q2
$44K Buy
+1,426
New +$48.4K 0.02% 88

Other funds holding PFE

Janiczek Wealth Management's PFE Position: Q2 2024 in Review

Janiczek Wealth Management reduced its Pfizer (PFE) stake by 27% in Q2 2024, selling an estimated $54K and leaving 5,370 shares worth $150K. The position accounts for 0.03% of the portfolio, ranked #225.

Janiczek Wealth Management first reported a position in PFE in Q2 2020 and has held it in 17 quarters since. The position peaked at $855K in Q2 2022. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Janiczek Wealth Management held 5,370 shares of Pfizer worth $150K as of Q2 2024.
  • Janiczek Wealth Management sold 1,960 Pfizer shares in Q2 2024, an estimated $54K.
  • Pfizer made up 0.03% of Janiczek Wealth Management's portfolio in Q2 2024, its #225 holding.
  • Janiczek Wealth Management first reported a position in Pfizer in Q2 2020 and has held it in 17 quarters since.
  • Janiczek Wealth Management's Pfizer position peaked at $855K in Q2 2022.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.